← FDA Drug Approvals (Drugs@FDA)

RANOLAZINE

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: MICRO LABS · Approved 2020-02-27

Drug application

FDA Application #

ANDA211745

Application type

Abbreviated New Drug Application (Generic)

Brand name

RANOLAZINE

Generic name

RANOLAZINE

Active ingredients

RANOLAZINE

Dosage form

TABLET, EXTENDED RELEASE

Route

ORAL

Marketing status

Prescription

Sponsor

MICRO LABS

Manufacturer

Micro Labs Limited

First approval

2020-02-27

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown